Tennessee Business Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tennessee Business Gazette.

Press releases published on November 18, 2026

ISSA Show North America Redefines Innovation with 2026 Award Winners Shaping the Future of Clean
HONA IMPORTANT DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Honeywell Aerospace Inc. Investors to Secure Counsel Before Important November 23 Deadline in Securities Class Action - HONA
Pyxis Oncology to Host Live Webcast on Updated MICVO Phase 1 Monotherapy Data Demonstrating Durable Response in 2L+ R/M HNSCC Following Late-Breaking Oral Presentation at EORTC-NCI-AACR Symposium
Diabetes Canada announces winners of its annual Healthcare Professional & Researcher Awards
Millicom (Tigo) announces upsize and pricing of Senior Notes due 2033   
Loblaw November Food Inflation Report
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Northrop Grumman Board Declares Quarterly Dividend
Azenta, Inc. Investor News: If You Have Suffered Losses in Azenta, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights
A Medicare Open Enrollment Checklist: Planning for 2027 Coverage
Fluence Energy, Inc. (FLNC) Class Action Lawsuit Seeks Recovery for Investors; November 27, 2026 Deadline – Contact Kessler Topaz Meltzer & Check, LLP
YIREN CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Yiren Digital Ltd. and Encourages Investors to Contact the Firm
REEcycle Holdings, Inc. and Hall Chadwick Acquisition Corp. Announce Additional $15.0 Million PIPE Commitments from Leading Institutional Stockholders
David Pomeranz Live: Multi-Platinum Singer-Songwriter to Perform and Share the Story Behind His Success at December 1 Book Talk in Diamond Bar
Press Release: Sanofi’s Infilbray approved in the US as the first medicine to treat neurological manifestations of Type 3 Gaucher disease
Communiqué de presse : Infilbray, de Sanofi, approuvé aux États-Unis comme le premier médicament indiqué dans le traitement des manifestations neurologiques de la maladie de Gaucher de type 3
O-I GLASS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against O-I Glass, Inc. and Encourages Investors to Contact the Firm
Enovix Distributes Dividend of Warrants to Stockholders
Primior Holdings Reports 102% YoY Net Income Growth in Q3 2026 as GAIA Marketplace Expands Listing Pipeline
Big Digital Energy Announces Chief Financial Officer Transition

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Tennessee Business Gazette

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.